Bloxiverz Injection
Product Images NDC 51754-1200

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Bloxiverz (NDC 51754-1200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exela Pharma Sciences, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Packaging label for Bloxiverz 1 mg/mL (10 mg/10 mL) Neostigmine Methylsulfate Injection, USP by Exela Pharma Sciences, LLC. The label specifies intravenous use, a 10 mL multiple-dose vial, storage instructions, and includes the NDC 51754-1220-1 with detailed ingredient and preservative information.*

FDA Label Image

Structure (Image 02)

Chemical structure diagram of the active ingredient in Bloxiverz 1 mg/mL, showing the molecular arrangement including a trimethylammonium and methanesulfonate group.*

FDA Label Image

Logo (Image 03)

FDA Label Image

0.5 mg Vial (Image 04)

Label for Bloxiverz (Neostigmine Methylsulfate injection, USP) showing strength 5 mg/10 mL (0.5 mg/mL) intravenous solution in a 10 mL multiple-dose vial. Manufactured for Exela Pharma Sciences, LLC. The label details ingredients and storage instructions, including protection from light and storage at 15° to 30°C (59° to 86°F).*

FDA Label Image

0.5 mg Carton (Image 05)

Bloxiverz (Neostigmine Methylsulfate Injection, USP) 5 mg/10 mL (0.5 mg/mL) label for a 10 mL multiple-dose vial. The label indicates the product is for intravenous use and is Rx only. Manufactured for Exela Pharma Sciences, LLC, Lenior, NC 28645. The label includes storage instructions, ingredient and preservative details, and a barcode.*

FDA Label Image

1 mg Vial (Image 06)

Bloxiverz 1 mg/mL (10 mg/10 mL) injection label for intravenous use in a 10 mL multiple-dose vial by Exela Pharma Sciences, LLC. Contains Neostigmine Methylsulfate with preservatives and instructions for storage and handling. Includes NDC and barcode information.*

FDA Label Image

1 mg Carton (Image 07)

Bloxiverz 1 mg/mL (10 mg/10 mL) Injection label showing Neostigmine Methylsulfate for intravenous use. The package contains 10 multiple-dose vials of 10 mL each. Labeler is Exela Pharma Sciences, LLC. The label includes storage instructions and a barcode.*

FDA Label Image

Image 08

Label for Bloxiverz 0.5 mg/mL (Neostigmine Methylsulfate Injection, USP) by Exela Pharma Sciences, LLC. The label indicates a 5 mg/10 mL concentration, multiple-dose vials, and includes storage and ingredient information. It specifies use for intravenous administration and provides handling instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.